5.0
13 Mar 2014
Recommend
CEO approval
Business outlook
Pros
It is devoted to a realistic concept of developing therapeutic antibodies against HIV-1. Employees are compensated adequately (comparable to UCSF) and have stock option as an incentive.
Cons
Focused effort and responsible people working hard to develop innovative products despite financing problems.